WHG
WX

Westwood Holdings Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Westwood Holdings Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-896,675
Closed -$38.7M – 445
2015
Q3 		$38.7M Buy
896,675
+275,155
+44% +$11.6M 0.34% 106
2015
Q2 		$26.3M Sell
621,520
-120,088
-16% -$5.06M 0.2% 135
2015
Q1 		$28.8M Buy
741,608
+500,512
+208% +$19.3M 0.22% 132
2014
Q4 		$8.12M Sell
241,096
-2,646
-1% -$93.5K 0.06% 187
2014
Q3 		$8.54M Buy
243,742
+8,398
+4% +$288K 0.07% 189
2014
Q2 		$7.73M Hold
235,344
– – 0.06% 186
2014
Q1 		$8.68M Buy
235,344
+21,175
+10% +$777K 0.07% 171
2013
Q4 		$8.22M Buy
214,169
+80,958
+61% +$2.56M 0.06% 163
2013
Q3 		$3.65M Sell
133,211
-1,289
-1% -$30.5K 0.03% 228
2013
Q2 		$2.82M Buy
+134,500
New +$2.63M 0.02% 250

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Westwood Holdings Group's WX Position: Q4 2015 in Review

Westwood Holdings Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 896,675 shares — an estimated $38.7M sold.

Westwood Holdings Group first reported a position in WX in Q2 2013 and held it in 10 quarters. The position peaked at $38.7M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Westwood Holdings Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Westwood Holdings Group sold 896,675 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $38.7M.
  • Westwood Holdings Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2013 and held it in 10 quarters.
  • Westwood Holdings Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $38.7M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Westwood Holdings Group's 13F filing for Q4 2015, filed 16 Feb 2016.